Sun Pharmaceutical Industries Ltd Share Price Today - Live Blog for March 18, 2026

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.89%, presenting both challenges and opportunities for investors. As of now, it's trading at 1778.40, and market participants are assessing the implications. The stock has a PE ratio of 39.3300, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.60% in its share price, and it currently trades at 1783.60 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.60%, a development that warrants careful analysis. Presently trading at 1783.60, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.11% slump and is currently trading at 1792.50. While the stock maintains a PE ratio of 39.3300, the industry PE is 31.9462, raising questions about valuation.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.11% drop, and it's now trading at 1792.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

After a -0.07% decline, Sun Pharmaceutical Industries Ltd shares are now trading at 1793.20. The stock has a PE ratio of 39.3300, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.07%, with the current market value at 1793.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.21%, with its current market value per share resting at 1798.20. This development highlights the stock's appeal to investors.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.21%. At this moment, it's actively trading at 1798.20, presenting an enticing opportunity for those in the market.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1795.50 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd share price surged by 0.06%. With its current market price standing at 1795.50 per share, this stock is garnering increased attention from the investment community.